Similar articles

• A review of the studies of the asthma mortality epidemic in New Zealand.

  Beasley R, Burgess C, Crane J, Pearce N. Beasley R, et al. Allergy Proc. 1995 Jan-Feb;16(1):27-32. doi: 10.2500/108854195778690075. Allergy Proc. 1995. PMID: 7768457 Review. No abstract available.
• Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.

  Beasley R, Pearce N, Crane J, Burgess C. Beasley R, et al. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):325-7. doi: 10.1159/000237016. Int Arch Allergy Immunol. 1995. PMID: 7613161 Review.
• Fenoterol and asthma mortality in New Zealand.

  Pearce N, Crane J, Burgess C, Grainger J, Beasley R. Pearce N, et al. N Z Med J. 1990 Feb 28;103(884):73-5. N Z Med J. 1990. PMID: 2308729 No abstract available.
• International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.

  Lanes SF, Birmann B, Raiford D, Walker AM. Lanes SF, et al. J Clin Epidemiol. 1997 Mar;50(3):321-8. doi: 10.1016/s0895-4356(96)00375-7. J Clin Epidemiol. 1997. PMID: 9120532
• End of the New Zealand asthma mortality epidemic.

  Pearce N, Beasley R, Crane J, Burgess C, Jackson R. Pearce N, et al. Lancet. 1995 Jan 7;345(8941):41-4. doi: 10.1016/s0140-6736(95)91159-6. Lancet. 1995. PMID: 7799709